- To take the test online, go to our secure Web site at www.nursingcenter.com/ce/ajn.
- To use the form provided in this issue, record your answers in the test answer section of the CE enrollment form below. Each question has only one correct answer. You may make copies of the form.
- Complete the registration information and course evaluation. Mail the completed enrollment form and registration fee to: Lippincott Williams and Wilkins, CE Group, 74 Brick Blvd., Bldg. 4, Suite 206, Brick, NJ 08723. You will receive your certificate in four to six weeks. For faster service, include a fax number and we will fax your certificate within two business days of receiving your enrollment form. You will receive your CE certificate of earned contact hours and an answer key to review your results. There is no minimum passing grade.
- Registration deadline is May 31, 2017.
DISCOUNTS AND CUSTOMER SERVICE
- Send in together two or more tests from any nursing journal published by Lippincott, Williams and Wilkins (LWW), and deduct $0.95 from the price of each test.
- We also offer CE accounts for hospitals and other health care facilities online at www.nursingcenter.com. Call 1-800-787-8985 for details.
LWW, publisher of AJN, will award the number of contact hours indicated for each continuing nursing education activity. LWW is accredited as a provider of continuing nursing education by the Commission on Accreditation of the American Nurses Credentialing Center (ANCC).
These activities are also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for the number of contact hours indicated. LWW is also an approved provider of continuing nursing education by the District of Columbia and Florida #50-1223. Your certificate is valid in all states.
The ANCC's accreditation status of the LWW Department of Continuing Education refers to its continuing nursing educational activities only and does not imply Commission on Accreditation approval or endorsement of any commercial product.
To provide information about the latest guideline for the management of atrial fibrillation, issued jointly in 2014 by the American Heart Association, the American College of Cardiology, and the Heart Rhythm Society.
After reading this article and taking this test, you will be able to
- recognize the assessment findings indicative of and risk factors for atrial fibrillation.
- identify components of the latest guideline for treatment of atrial fibrillation.
- How does atrial fibrillation rank as a common chronic cardiac dysrhythmia?
- Nearly what percentage of cases of atrial fibrillation occur in people over 65 years of age?
- Results from the Framingham Heart Study indicate that one's lifetime risk of developing atrial fibrillation is
- 1 in 4.
- 1 in 5.
- 1 in 6.
- In atrial fibrillation, multiple atrial cells
- cease electrical activity.
- behave as individual pacemakers.
- increase blood flow to the left ventricle.
- Of the following, which is the most common complication of atrial fibrillation?
- hemodynamic compromise
- torsade de pointes
- heart failure
- Data from the Centers for Medicare and Medicaid Services demonstrate that, among beneficiaries with atrial fibrillation, the most common comorbidity is
- chronic kidney disease.
- A common symptom of atrial fibrillation is
- chest pain.
- Assessment findings typically include a pulse that is
- On an electrocardiogram, atrial fibrillation appears as
- an erratic baseline.
- inverted P waves.
- a wide QRS complex.
- In both the CHADS2 and the CHA2DS2-VASc stroke risk stratification tools, the D stands for
- diastolic pressure.
- Patients with atrial fibrillation who have mechanical heart valves or hemodynamically significant mitral stenosis should be treated with which of the following anticoagulants?
- With which of the following drugs has monotherapy been found ineffective for preventing stroke in patients with atrial fibrillation?
- For patients who are asymptomatic and show no signs of heart failure, the 2014 American Heart Association/American College of Cardiology/Heart Rhythm Society guideline recommends a resting heart rate of less than
- 110 bpm.
- 120 bpm.
- 130 bpm.
- In the Atrial Fibrillation Follow-Up Investigation of Rhythm Management study, which of the following drug classifications was found most effective in achieving heart rate control?
- cardiac glycosides
- calcium channel blockers
- According to a recent meta-analysis, which of the following drugs was found most effective for maintaining normal sinus rhythm once atrial fibrillation was converted?
- In the same meta-analysis, which of the following drugs for maintaining normal sinus rhythm after cardioversion was found to have the lowest rate of adverse events?
- If cardioversion results in normal sinus rhythm but atrial fibrillation recurs, the new guideline recommends which of the following treatment modalities?
- use of a biphasic defibrillator
- an antiarrhythmic medication
- lowering the defibrillation threshold
- In a study of patients undergoing the most recent Cox maze procedure, up to what percentage were free from atrial fibrillation at 6 months’ follow-up?